Any current/future capex/capital investment/strategic investment?

Investment in Engineering & Construction (E&C) to drive growth initiated in December 2018. New manufacturing line for BS6 compliant emission control materials being set up. Capacity expansion for hand sanitizers and guard line. Manufacturing new ranges of disinfectants underway. Continuing capex plans focused on reinvesting for growth; plans to extend into the future. Execution of new local manufacturing projects to expand capacity in hand sanitizers, disinfectants, and BS-VI materials. Capex tends to be lumpy; no fixed annual capex-to-sales ratio currently. Focus on sectors benefiting from go

Future growth expectations in sales/revenue/volumes?

The consumer business has shown growth, increasing its portfolio mix by about 1.5 percentage points over four years, currently at about 11.6% of total sales, with potential to grow towards the parent company's 15-16% benchmark. Focus on strengthening brand presence and broadening the product portfolio in cleaning, scouring, and home improvement categories. Accelerating digital commerce and e-commerce channels to drive consumer business growth. Capex investments planned for expansion, including new manufacturing lines for BS6 emission control materials, increased capacity for hand sanitizers an

Future growth expectations in earnings/operating earnings/profits/EPS?

The consumer business, considered the "star segment," has shown margin and return improvements but remains a small portion (~11.6%) with potential to grow towards the parent company's benchmark of 15-16%. Growth will be driven by strengthening the brand, broadening the product portfolio in cleaning, scouring, and home improvement categories, and accelerating digital commerce adoption. The company continues to invest in capital expenditure with a lumpy but ongoing capex plan focusing on new manufacturing lines for BS6 emission control materials, hand sanitizers, disinfectants, etc. Despite weak

3M India LtdQ1 FY21Diversified

3M India Ltd Q1 FY21 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹28,990P/E: 74.1Market Cap: ₹32.7K CrSector: Diversified

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

The consumer business has shown growth, increasing its portfolio mix by about 1.5 percentage points over four years, currently at about 11.6% of total sales, with potential to grow towards the parent company's 15-16% benchmark.
Focus on strengthening brand presence and broadening the product portfolio in cleaning, scouring, and home improvement categories.
Accelerating digital commerce and e-commerce channels to drive consumer business growth.
Capex investments planned for expansion, including new manufacturing lines for BS6 emission control materials, increased capacity for hand sanitizers and disinfectants.
Leveraging government Production Linked Incentive programs in sectors like smartphone manufacturing.
Continued innovation with new products in vehicle interior cleaning, road safety, and multipack SKUs.
Utilization of global 3M network capabilities for intellectual property, digital marketing, and data analytics to support growth.
Overall, a focus on sustainable growth and leveraging strengths despite market challenges.

Margin guidance

Category 3

The consumer business, considered the "star segment," has shown margin and return improvements but remains a small portion (~11.6%) with potential to grow towards the parent company's benchmark of 15-16%.
Growth will be driven by strengthening the brand, broadening the product portfolio in cleaning, scouring, and home improvement categories, and accelerating digital commerce adoption.
The company continues to invest in capital expenditure with a lumpy but ongoing capex plan focusing on new manufacturing lines for BS6 emission control materials, hand sanitizers, disinfectants, etc.
Despite weak external conditions and a 1% revenue decline in FY2019-20, improved operational discipline and cost management support profitability.
New product launches and market expansion in safety, hygiene, and road safety provide growth avenues.
The company expects sustainable growth leveraging its global capabilities and local manufacturing projects.
COVID-19-related disruptions caused temporary setbacks, but long-term growth drivers remain intact.

See what 3M India Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

- The company’s capex plans are described as "lumpy," with no fixed annual percentage of sales allocated yet, indicating selective investment rather than continuous large fundraising. - In December 2018, investments were made in Engineering & Construction (E&C) for growth, including new manufacturing lines (e.g., BS6 emission control materials, hand sanitizers, disinfectants). - There is a strong focus on reinvesting cash and capex for growth, with plans continuing into the future. - Multiple shareholder questions about large cash reserves (approx. Rs. 780 crores) addressed use primarily for reinvestment and growth, not explicit dividend distribution. - No specific mention in the text of any current or upcoming fundraising through debt or equity. **Summary:** No explicit plans for new debt or equity fundraising are reported; the company prefers to use existing cash and targeted capex investments for growth.

Order book

The transcript on page 14 does not provide specific information about the current or expected order book or pending orders for the company. The discussion mainly covers topics such as consumer business growth, reasons for discontinuing the graphics business, capex plans, dividend policy, and shareholder questions regarding financial performance and company strategy. No direct mention or data related to the order book or pending orders is available in the provided pages.

See what 3M India Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Investment in Engineering & Construction (E&C) to drive growth initiated in December 2018.
New manufacturing line for BS6 compliant emission control materials being set up.
Capacity expansion for hand sanitizers and guard line.
Manufacturing new ranges of disinfectants underway.
Continuing capex plans focused on reinvesting for growth; plans to extend into the future.
Execution of new local manufacturing projects to expand capacity in hand sanitizers, disinfectants, and BS-VI materials.
Capex tends to be lumpy; no fixed annual capex-to-sales ratio currently.
Focus on sectors benefiting from government Production Linked Incentive programs, such as smartphone manufacturing.

Track 3M India Ltd — get its next earnings analysis in your feed

How does 3M India Ltd rank vs peers in Diversified?

Pro feature

This3M India Ltd

Rev 4Mar 3

See where 3M India Ltd sits in DiversifiedSee which companies these are, and every other name in the sector.Open rankings

How does 3M India Ltd rank in Diversified?

Compare 3M India Ltd against every Diversified company (Q1 FY21) on revenue, margins and earnings-call signals.

View Diversified leaderboard →

What 3M India Ltd's management said in earlier quarters

Others in Diversified this season

DCM Shriram Ltd (Q2 FY27)
Chemicals & Vinyl: Rs 1,577 cr, up 42% YoY . Key investor presentation takeaways from DCM Shriram Ltd's Q2 FY27 investor presentation — and how it ranks against
Godrej Industries Ltd (Q4 FY25)
Q4 FY 2024-25 Total Income (Consolidated): ₹6,400 crore, up 25% YoY from ₹5,103 crore (Page 6). Key concall takeaways from Godrej Industries Ltd's Q4 FY25…
Godrej Industries Ltd (Q1 FY26)
Consolidated Total Income: ₹5,719 crore in Q1 FY26, up 9% YoY from ₹5,259 crore in Q1 FY25. Key concall takeaways from Godrej Industries Ltd's Q1 FY26 earnings…
Godrej Industries Ltd (Q2 FY26)
Consolidated Total Income:** ₹6,290 crore, up 23% YoY (Page 6) . Key concall takeaways from Godrej Industries Ltd's Q2 FY26 earnings call — and how it ranks…

Compare:vs Godrej Industries Ltd vs DCM Shriram Ltd vs TTK Healthcare Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →